Trybeca-1: A randomized, phase 3 study of eryaspase in combination with chemotherapy versus chemotherapy alone as second-line treatment in patients with pancreatic adenocarcinoma (NCT03665441).

Hammel, P; Berardi, R; Van Cutsem, E; Feliu, J; Greil, R; Wasan, HS; Metges, JP; Nygren, P; Osterlund, PJ; Parner, V; Seufferlein, T; Gupta, A; Salesse, S; Biswasbaldwin, N; Ibrahim, A; Youssoufian, H; El-Hariry, I; Hidalgo, M

View this publication in the PUBMED database